"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
The injectable form of Tigan® (trimethobenzamide hydrochloride injectable) is contraindicated in pediatric patients and in patients with known hypersensitivity to trimethobenzamide.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/26/2008
Additional Tigan Injection Information
Tigan Injection - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.